Ubs Oconnor LLC Jazz Pharmaceuticals PLC Transaction History

Ubs Oconnor LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $878,400 - $1.05 Million	-7,200 Reduced 50.65%	7,014 $907,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $1.74 Million - $2.09 Million	14,214 New	14,214 $1.76 Billion
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $171,092 - $204,920	1,277 Added 5.0%	26,824 $3.93 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $4.34 Million - $5.35 Million	-33,493 Reduced 56.73%	25,547 $0
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $759,540 - $967,080	6,000 Added 11.31%	59,040 $7.87 Billion
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $6.12 Million - $7.29 Million	43,226 Added 440.45%	53,040 $8.27 Million
Q1 2022 May 16, 2022	BUY	$129.64 - $160.7 $1.27 Million - $1.58 Million	9,814 New	9,814 $1.53 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.